Zoetis Inc.
ZTS
$167.00
-$2.90-1.71%
| Weiss Ratings | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | B | |||
| Rating Factors | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.48 | |||
| Price History | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.02% | |||
| 30-Day Total Return | -0.32% | |||
| 60-Day Total Return | -4.46% | |||
| 90-Day Total Return | -11.40% | |||
| Year to Date Total Return | 3.01% | |||
| 1-Year Total Return | -8.88% | |||
| 2-Year Total Return | 0.37% | |||
| 3-Year Total Return | -8.72% | |||
| 5-Year Total Return | 24.43% | |||
| 52-Week High % Change | -15.19% | |||
| 52-Week Low % Change | 17.33% | |||
| Price | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $200.33 | |||
| 52-Week Low Price | $144.80 | |||
| 52-Week Low Price (Date) | Apr 22, 2024 | |||
| 52-Week High Price (Date) | Sep 19, 2024 | |||
| Valuation | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 76.08B | |||
| Enterprise Value | 80.92B | |||
| Price/Earnings (TTM) | 31.08 | |||
| Earnings Per Share (TTM) | 5.47 | |||
| Earnings Per Share Growth | 7.85% | |||
| Price/Earnings To Growth | 3.96 | |||
| Price/Sales (TTM) | 8.28 | |||
| Price/Book (Q) | 15.97 | |||
| Enterprise Value/Revenue (TTM) | 8.74 | |||
| Price | $167.00 | |||
| Enterprise Value/EBITDA (TTM) | 21.13 | |||
| Enterprise Value/EBIT | 23.85 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 451.10M | |||
| Dividend Yield | 1.06% | |||
| Div. Per Share (Most Recent) | $0.50 | |||
| Dividend Per Share (TTM) | $1.80 | |||
| Payout Ratio (TTM) | 31.62% | |||
| Dividend Per Share (Most Recent) | $0.50 | |||
| Company Info | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 973 822 7000 | |||
| Address | 10 Sylvan Way Parsippany, NJ 07054 | |||
| Website | www.zoetis.com | |||
| Country | United States | |||
| Year Founded | 1950 | |||
| Profitability | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 36.65% | |||
| Profit Margin | 26.85% | |||
| Management Effectiveness | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 14.87% | |||
| Return on Equity | 51.14% | |||
| Income Statement | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 9.26B | |||
| Total Revenue (TTM) | 9.26B | |||
| Revenue Per Share | $20.52 | |||
| Gross Profit (TTM) | 6.54B | |||
| EBITDA (TTM) | 3.83B | |||
| EBIT (TTM) | 3.39B | |||
| Net Income (TTM) | 2.49B | |||
| Net Income Avl. to Common (TTM) | 2.49B | |||
| Total Revenue Growth (Q YOY) | 4.70% | |||
| Earnings Growth (Q YOY) | 11.09% | |||
| EPS Diluted (TTM) | 5.47 | |||
| EPS Diluted Growth (Q YOY) | 13.17% | |||
| Balance Sheet | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.99B | |||
| Cash Per Share (Q) | $4.40 | |||
| Total Current Assets (Q) | 5.99B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 4.77B | |||
| Current Ratio (Q) | 1.754 | |||
| Book Value Per Share (Q) | $10.64 | |||
| Total Assets (Q) | 14.24B | |||
| Total Current Liabilities (Q) | 3.41B | |||
| Total Debt (Q) | 6.83B | |||
| Total Liabilities (Q) | 9.47B | |||
| Total Common Equity (Q) | 4.77B | |||
| Cash Flow | ZTS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -315.00M | |||
| Cash from Financing (TTM) | -2.66B | |||
| Net Change in Cash (TTM) | -54.00M | |||
| Levered Free Cash Flow (TTM) | 2.37B | |||
| Cash from Operations (TTM) | 2.95B | |||
